Gene: MLST8
Official Full Name: MTOR associated protein, LST8 homologprovided by HGNC
Gene Summary: Enables protein serine/threonine kinase activator activity and protein-macromolecule adaptor activity. Involved in TOR signaling; positive regulation of TOR signaling; and regulation of actin cytoskeleton organization. Part of TORC1 complex and TORC2 complex. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO10220 | MLST8 Knockout cell line (HeLa) | Human | MLST8 | 1:3~1:6 | Negative | Online Inquiry |
KO10221 | MLST8 Knockout cell line (HCT 116) | Human | MLST8 | 1:2~1:4 | Negative | Online Inquiry |
KO10222 | MLST8 Knockout cell line (HEK293) | Human | MLST8 | 1:3~1:6 | Negative | Online Inquiry |
MLST8 Gene Knockout Cell Lines represent a sophisticated research tool designed to facilitate the investigation of cellular processes regulated by the mTOR signaling pathway. MLST8, or mammalian lethal with SEC13 protein 8, plays a crucial role in mTORC1 (mammalian target of rapamycin complex 1) signaling, making these knockout cell lines invaluable for studying metabolic regulation, cell growth, and apoptosis.
The key function of the MLST8 gene knockout is to disrupt the normal expression and function of MLST8, thereby allowing researchers to observe the downstream effects of mTOR signaling inhibition. By utilizing CRISPR-Cas9 technology, these cell lines provide precise genetic modifications that lead to loss-of-function phenotypes. This allows scientists to explore the biological significance of MLST8 in areas such as cell proliferation, nutrient sensing, and tumorigenesis under various experimental conditions.
Scientifically, MLST8 Gene Knockout Cell Lines are essential in both basic and applied research settings. Their applications extend to drug discovery and development, particularly in cancer therapeutics where aberrant mTOR signaling is a common hallmark. In clinical contexts, understanding the role of MLST8 can inform targeted therapies and individualized treatment strategies for diseases linked to the dysregulation of mTOR pathways.
One of the standout advantages of MLST8 Gene Knockout Cell Lines is their specificity and efficiency in targeting endogenous gene functions, in stark contrast to broad-spectrum inhibitors that may produce off-target effects. This specificity not only enhances the reliability of experimental outcomes but also increases reproducibility across multiple studies.
For researchers and clinicians looking to deepen their understanding of mTOR signaling dynamics, MLST8 Gene Knockout Cell Lines offer an indispensable resource. Our company boasts extensive experience in producing high-quality biological products, backed by rigorous scientific validation. With our advanced cell line technologies, we are dedicated to aiding your research endeavors in the field of molecular biology and translational medicine.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.